Ironwood Pharmaceuticals (IRWD) Profit After Tax (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Profit After Tax of $40.8 million for Q1 2026, up 1891.43% sequentially from -$2.3 million in Q4 2025, and up 209.06% YoY from $13.2 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Profit After Tax (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Profit After Tax for 17 years, with the latest figure at $40.8 million in Q1 2026.
- Quarterly Profit After Tax rose 209.06% year-over-year to $40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.2 million (up 415.9% YoY) and the FY2025 annual result came in at $24.0 million, up 2629.2% from the prior year.
- Profit After Tax climbed to $40.8 million in Q1 2026 per IRWD's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Profit After Tax peaked at $50.3 million in Q3 2022 and troughed at -$1.1 billion in Q2 2023.
- A 5-year average of -$46.5 million and a median of $14.0 million in 2023 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax tumbled 3038.18% in 2023, then jumped 2844.07% in 2025.
- Over 5 years, Profit After Tax stood at $48.9 million in 2022, then tumbled by 103.57% to -$1.7 million in 2023, then surged by 229.28% to $2.3 million in 2024, then slumped by 200.89% to -$2.3 million in 2025, then surged by 1891.43% to $40.8 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $40.8 million, -$2.3 million, and $40.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 688.03 Mn | 608.91 Mn | - | 51.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.29 Mn |
| Mar 31, 2026 | 40.77 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 40.08 Mn |
| Jun 30, 2025 | 23.60 Mn |
| Mar 31, 2025 | -37.39 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 3.65 Mn |
| Jun 30, 2024 | -860,000.00 |
| Mar 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Sep 30, 2023 | 13.95 Mn |
| Jun 30, 2023 | -1.09 Bn |
| Mar 31, 2023 | 45.71 Mn |
| Dec 31, 2022 | 48.87 Mn |
| Sep 30, 2022 | 50.32 Mn |
| Jun 30, 2022 | 37.08 Mn |
| Mar 31, 2022 | 38.80 Mn |
| Dec 31, 2021 | 41.37 Mn |
| Sep 30, 2021 | 55.85 Mn |